Litigation Update : Judge Moving Forward as Planned According to the district judge assigned to oversee the Zantac MDL, the litigation will continue to move forward despite COVID-19 changes. To comply with social distancing and safe health guidance, the court will not have in-person conferences but instead do the litigation activities via video conferencing. The…
Losartan Lawsuit The FDA reported that they have found traces of unexpected impurities in certain batches of Losartan. The impurity that has been detected is N-Methylnitrosobutyric acid or NMBA. The company is only recalling batches of Losartan that contain more than the acceptable daily intake levels of NMBA set by the FDA. Losartan is an…
When drug products are removed from shelves and taken off the market by the manufacturers, it is done so in accordance with a drug recall – either voluntarily or involuntarily. When a recall is initiated by the manufacturer, it is a voluntary recall; the U.S. FDA can also request a recall. Recalls can be initiated…